WHO Model List
carbamazepine
International nonproprietary name (English: carbamazepine). Brand names vary by country.
Indications retained by WHO
Epilepsy or seizures; Bipolar or related disorders; Trigeminal neuralgia.
Listed forms and strengths
- Oral > Liquid: 100 mg per 5 mL
- Oral > Solid > tablet: 400 mg (scored); 200 mg (chewable); 100 mg (chewable); 200 mg (scored); 100 mg (scored)
- Oral > Solid > tablet: 200 mg (scored); 400 mg; 100 mg (scored)
- Oral > Solid > capsule: 100 mg (extended-release); 200 mg (extended-release); 300 mg (extended-release)
Forms retained in the model list; presentations available in each country may differ.
General information from the WHO list. It replaces neither the prescription nor the leaflet: dosage and duration are for the doctor or pharmacist to decide.
Source: WHO electronic Essential Medicines List (2025 edition), checked on 14/11/2026. An error or an imprecision? Let us know